Loading interface...

Motiza 50 MG Tablet

Manufactured byJb Chemicals And Pharmaceuticals Ltd.
ContainsItopride
Description

Motiza 50 MG Tablet is an effectively increases movement of food and facilitates emptying of the stomach. It is used for the treatment of Gastroesophageal Reflux Disease, Functional Dyspepsia, and other associated motility disorders.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Side effects

Major & minor side effects for Motiza 50 MG Tablet

  • Diarrhea
  • Abdominal pain
  • Headache
  • Nausea
  • Decrease in white blood cells and platele ts
  • Gynacomastia
  • Allergic skin reaction
  • Increased liver enzyme levels
  • Jaundice

Uses of Motiza 50 MG Tablet

What is it prescribed for?

  • Non-ulcer dyspepsia
  • Gastroparesis
  • Nausea and vomiting
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 30-60 minutes of administration.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for 4-6 hours. However, it is subject to vary from one patient to another.
  • Is it safe to consume alcohol while taking this medicine?
    Reduce or minimize the uptake of alcohol while taking this medicine. Contact your doctor if any unwanted effects are observed.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    Use of this medicine in pregnant women is not recommended unless absolutely necessary. It should be used only if the potential benefits outweigh the associated risks. Consult your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Use of this medicine in breastfeeding mothers is not recommended. If the need of this medicine is absolutely necessary then breastfeeding should be discontinued prior to uptake. Consult your doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known history of allergy to Itopride or any other ingredient present along with it.

Gastrointestinal haemorrhage

This medicine is not recommended for use in patients having internal bleeding of the stomach and intestine. This may be attributed to various reasons including a ruptured bowel (Gastrointestinal Perforation).

Mechanical bowel obstruction

This medicine is not recommended for use in patients having a blockage in the intestine.

Parkinson's disease

This medicine is not recommended for use in patients having dopamine related disorders like Parkinson's disease.
Warnings for special population

Pregnancy

Use of this medicine in pregnant women is not recommended unless absolutely necessary. It should be used only if the potential benefits outweigh the associated risks. Consult your doctor before taking this medicine.

Breast-feeding

Use of this medicine in breastfeeding mothers is not recommended. If the need of this medicine is absolutely necessary then breastfeeding should be discontinued prior to uptake. Consult your doctor before taking this medicine.
General warnings

Pediatric use

Use of this medicine is not recommended in children who are less than 16 years old.

Geriatric use

This medicine should be used with caution in elderly patients as the risk of side effects are increasingly high.

Bleeding of stomach and intestine

Report any instance indicating bleeding of the stomach like presence of blood in stools, black or coffee colored stools to the doctor. This medicine should not be used if bleeding is evident or even suspected.

Mechanical obstruction of stomach

Report any incidence indicating intestinal blockage like severe bloating, nausea, vomiting, severe abdominal cramps, constipation etc to the doctor. Use of this medicine is not recommended in such cases.

Other medicine

Report the use of all other medicine including supplements and herbs to the doctor while receiving this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, then the missed dose can be skipped.

Overdose

The likelihood of an overdose is very less. However, contact your doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Use of alcohol in excessive amounts can cause acidity and the risk of adverse effects are very high while taking it with this medicine.

Instructions

Reduce or minimize the uptake of alcohol while taking this medicine. Contact your doctor if any unwanted effects are observed.
Interaction with Medicine

Anticholinergic drugs

Disease interactions

Disease

Information not available.
Food interactions
It is advised to not consume grapefruit juice in large quantities while taking this medicine as the likelihood of unwanted effects increase. Consult your doctor if an undesirable effect is experienced.
Lab interactions
Information not available.
Take Motiza 50 MG Tablet as instructed by the doctor. Your doctor may make some changes in the dose based on symptoms and age. You should adhere to all the instructions given by the doctor.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine acts by increasing the concentration of chemicals at the nerve endings causing an increase in stomach muscle movement. This helps in the faster movement of food from the stomach to the intestine.
Legal Status

Approved

Unknown

Unknown

Approved

Classification

Category

Gastrointestinal agents

Schedule

Schedule H

[Internet]. 2017 [cited 24 March 2017]. Available from: ott/content/dam/bss/divisionalsites/epd/pk/Product%20Information/Leaflet%20Ganaton%2050.pdf

https://www.medicine.abb

[Internet]. 2017 [cited 24 March 2017]. Available from:

http://www.fouda.com/sites/default/files/10659.pdf

Shenoy KT e. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 24 March 2017]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/14579989

VigiAccess [Internet]. Vigiaccess.org. 2017 [cited 24 March 2017]. Available from:

http://www.vigiaccess.org/

Itopride | C20H26N2O4 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 24 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/3792#section=Top
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 16 Nov 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.